ED—Apologies—I got distracted with trying to raise money to support our efforts to develop a new neuroprotectant for use in stroke and this slipped off my radar. BTW the call with the FDA was very supportive and they are opening our IND. It sounds like we are talking about generalities here. If one assumes theContinue reading “Post. 17 Aug 2016.”